methylprednisolone suleptanate

09/01/2014 - "From the payer's perspective, the NHI cost associated with moderate to severe psoriasis (sPsO) was NT$41,525 and that with mild psoriasis (mPsO) was NT$14,816. "
07/01/2011 - "The cases were further classified into moderate to severe psoriasis (sPsO) for those who had previously received systemic therapy during the study period and mild psoriasis (mPsO) for those who had not. "

08/01/2015 - "Twenty-six patients with thoracolumbar post-tubercular kyphosis underwent mPSO. "
08/01/2015 - "The purpose of this study was to evaluate the clinical and radiographic outcomes of modified pedicle subtraction osteotomy (mPSO) for thoracolumbar post-tubercular kyphosis in pediatric patients. "
01/01/2021 - ": Each patient underwent posterior vertebral column resection (PVCR) for the correction of kyphosis, and mPSO was used for decompression of the stenotic adjacent segments.Outcome"
08/01/2015 - "Modified pedicle subtraction osteotomy (mPSO) is effective and reliable for thoracolumbar post-tubercular kyphosis in pediatric patients."
08/01/2015 - "From January 2008 to August 2012, 26 consecutive pediatric patients with thoracolumbar post-tubercular kyphosis underwent modified pedicle subtraction osteotomy (mPSO). "

12/01/1996 - "In this study, methylprednisolone suleptanate and methylprednisolone sodium succinate have been shown to be therapeutically equivalent in the treatment of patients hospitalized with acute asthma."
12/01/1996 - "Seventy-two hour comparison of methylprednisolone suleptanate and methylprednisolone sodium succinate in patients with acute asthma."
09/01/2000 - "Methylprednisolone suleptanate (Promedrol) is a prodrug of methylprednisolone being developed by Pharmacia Corp (formerly Pharmacia & Upjohn) for the treatment of asthma. "
12/01/1996 - "The efficacy and safety of the methylprednisolone prodrugs methylprednisolone suleptanate and methylprednisolone sodium succinate were evaluated in a multicentre, randomised, double-blind, double-dummy parallel study of 88 patients hospitalised with acute asthma. "

04/01/2012 - "When appropriately selected, both the mPSO and the VCR can be expected to yield satisfactory reduction of post-tuberculosis kyphotic deformities. "
01/01/2021 - "Adjacent segment degeneration is an important risk factor for causing neurologic deficits, and posterior surgical management for angular kyphosis of thoracolumbar tuberculosis and spinal decompression using mPSO are recommended."

09/01/2000 - "Animal models have also demonstrated the use of methylprednisolone suleptanate for the treatment of nephritis and hypotension. "
02/01/1994 - "To establish the regimen for beneficial prolonged treatment with glucocorticoids on nephritis, we investigated the antinephritic effect of methylprednisolone suleptanate (MPS) and its influence on adrenal function by intermittent administration (IA) in comparison with daily administration (DA) in crescentic-type anti-GBM nephritic rats. "